Evidence map›Paper›PMID 37342158›Full record

ArticleBio-protocol2023

Large-scale Isolation of Exosomes Derived from NK Cells for Anti-tumor Therapy.

Heyong Luo, Jing Zhang, Anqing Yang, Weiwei Ouyang, Shiqi Long, Xiaojin Lin, Na Yang, Zhiru Yang, Yingchun Zhang, Wei Yang and 4 more

Abstract read
In one paragraph

Article in Bio-protocol, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. [Research progress on the mechanisms and optimization strategies of mesenchymal stem cell-derived exosomes in the treatment of liver diseases].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2026
    Review
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Heyong LuoCenter for Tissue Engineering and Stem Cell Research, Guizhou Medical University, Guiyang, China.
Jing ZhangDepartment of Biology, College of Basic Medical Sciences, Guizhou Medical University, Guiyang, China.
Anqing YangCenter for Tissue Engineering and Stem Cell Research, Guizhou Medical University, Guiyang, China.
Weiwei OuyangDepartment of Thoracic Oncology, The Affiliated Hospital/The Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, China.
Shiqi LongDepartment of Immunology, College of Basic Medical Sciences, Guizhou Medical University, Guiyang, China.
Xiaojin LinCenter for Tissue Engineering and Stem Cell Research, Guizhou Medical University, Guiyang, China.
Na YangCenter for Tissue Engineering and Stem Cell Research, Guizhou Medical University, Guiyang, China.
Zhiru YangCenter for Tissue Engineering and Stem Cell Research, Guizhou Medical University, Guiyang, China.
Yingchun ZhangDepartment of Biology, College of Basic Medical Sciences, Guizhou Medical University, Guiyang, China.
Wei YangDepartment of Oncology, Guizhou Medical University, Guiyang, China.
Qiyuan CheCenter for Tissue Engineering and Stem Cell Research, Guizhou Medical University, Guiyang, China.
Yuxin YangCenter for Tissue Engineering and Stem Cell Research, Guizhou Medical University, Guiyang, China.
Ting GuoDevelopment and Related Diseases of Women and Children Key Laboratory of Sichuan Province.
Xing ZhaoCenter for Tissue Engineering and Stem Cell Research, Guizhou Medical University, Guiyang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Exosomes are lipid bilayer-enclosed vesicles, actively secreted by cells, containing proteins, lipids, nucleic acids, and other substances with multiple biological functions after entering target cells. Exosomes derived from NK cells have been shown to have certain anti-tumor effects and potential applications as chemotherapy drug carriers. These developments have resulted in high demand for exosomes. Although there has been large-scale industrial preparation of exosomes, they are only for generally engineered cells such as HEK 293T. The large-scale preparation of specific cellular exosomes is still a major problem in laboratory studies. Therefore, in this study, we used tangential flow filtration (TFF) to concentrate the culture supernatants isolated from NK cells and isolated NK cell-derived exosomes (NK-Exo) by ultracentrifugation. Through a series of characterization and functional verification of NK-Exo, the characterization, phenotype, and anti-tumor activity of NK-Exo were verified. Our study provides a considerably time- and labor-saving protocol for the isolation of NK-Exo.

Indexed as

ExosomeImmunotherapyNatural killer cellsTangential flow filtrationUltracentrifugation

Identifiers

PMID37342158
PMCPMC10278036

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.